Last reviewed · How we verify

NCT06684210: EOI

Study of the Clinical Effect of External Oblique Muscle Intercostal Muscle Plane Block in Abdominal Surgery

Completed NA Last updated 12 November 2024
What this trial tests

NA trial testing Intercostal plane block of the external oblique muscle in Nerve Block in 60 participants. Completed in 1 February 2024.

Timeline
1 March 2023
Primary endpoint
1 January 2024
1 February 2024

Quick facts

Lead sponsorThe First Hospital of Qinhuangdao
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposeprevention
Enrollment60
Start date1 March 2023
Primary completion1 January 2024
Estimated completion1 February 2024
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

The First Hospital of Qinhuangdao

Who can join

Adults 18 to 60, any sex, with Nerve Block or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to apply external oblique intercostal muscle plane block in thoracoabdominal resection, and to explore its effect on perioperative analgesia and rehabilitation quality in patients undergoing thoracoabdominal surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

Other The First Hospital of Qinhuangdao trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06684210.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing